Table 2. Timelines and outcomes for 15 hospitalized adults with nosocomial pandemic (H1N1) 2009, United Kingdom, 2009–2010.
| Patient no. | Age, y/sex | Duration, d |
Maximum level of care* | Outcome† | |
|---|---|---|---|---|---|
| Hospital admission to symptom onset | Symptom onset to receipt of antiviral therapy | ||||
| 1 | 51/F | 26 | 0 | 0/1 | Unknown data |
| 2 | 44/M | 14 | 0 | 0/1 | Recovered |
| 3 | 34/M | 8 | 0 | 3 | Died |
| 4 | 18/F | 4 | Not given | 2 | Transferred to other hospital |
| 5 | 48/M | 9 | 4 | 0/1 | Recovered |
| 6 | 43/M | 5 | 0 | 0/1 | Recovered |
| 7 | 51/M | 29 | 0 | 3 | Died |
| 8 | 39/F | 5 | 3 | 0/1 | Died |
| 9 | 76/M | 11 | Not given | 3 | Died |
| 10 | 45/F | 24 | 2 | 0/1 | Recovered |
| 11 | 44/F | 14 | Not given | 3 | Transferred, improved |
| 12 | 22/M | 5 | 0 | 3 | Died |
| 13 | 52/M | 78 | 1‡ | 3 | Recovered |
| 14 | 33/F | 7 | 3 | 0/1 | Recovered |
| 15 | 60/M | 13 | Not given | 3 | Recovered |
*Level 0 care is given to patients whose care needs can be met through normal ward care. Level 1 care is given to patients at risk for a deteriorating condition or recently relocated from higher levels of care whose needs can be met in an acute-care ward with additional advice and support from the critical-care team. Level 3 care is given to patients requiring advanced respiratory support alone or basic respiratory support and support for >2 organ systems; this level includes all patients with complex conditions that required support for multiorgan failure (intensive care unit). Level 2 care is given to patients requiring more detailed observation or intervention, including support for a single failing organ system and those changing from higher levels of care (high dependency unit). †Deaths were attributed to pandemic (H1N1) 2009. ‡Oseltamivir was replaced with zanamivir on day 5 because of identification of the H275Y drug-resistance mutation.